Skip to content

Cognitive-Behavioral Therapy for Adults With Attention-Deficit/Hyperactivity Disorder Inattentive Presentation

Group-Based Cognitive-Behavioral Therapy for Adults With Attention-Deficit/Hyperactivity Disorder Inattentive Presentation: Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04090983
Enrollment
108
Registered
2019-09-16
Start date
2019-09-01
Completion date
2024-12-31
Last updated
2025-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ADHD Predominantly Inattentive Type

Brief summary

Using a randomized controlled design, standard treatment of group cognitive-behavioral therapy (CBT) according to the Hesslinger protocol is compared to a newly developed group treatment specifically designed for adult patients with ADHD inattentive presentation (ADHD-I) called CBT for ADHD-I (CADDI). Research setting is psychiatric outpatient clinics. Research hypotheses include: 1. The CADDI protocol is more effective than standard treatment in terms of behavioral activation, procrastination, depressive symptoms, functional impairment, and quality of life, 2. Is equally effective in terms of ADHD symptoms, 3. Is more appreciated and tolerable, and 4. Outcome is mediated by mindful awareness. Effects are followed up at 6 and 12 months post treatment.

Interventions

BEHAVIORALCognitive-behavioral therapy (Hesslinger protocol)

Cognitive-behavioral therapy in a group format focusing on improving symptoms of ADHD, specifically by using skills in counteracting hyperactivity and impulsiveness, and promoting mindful awareness.

BEHAVIORALCognitive-behavioral therapy (CADDI protocol)

Cognitive-behavioral therapy in a group format focusing on improving inattentive symptoms of ADHD, specifically by using skills in organizing, executing, and completing activity, and promoting mindful awareness.

Sponsors

Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Principal diagnosis of ADHD inattentive presentation 2. 18 years of age or older 3. If on medication, it needs to be well-established since three months, and 4. Prior psycho-educational intervention

Exclusion criteria

1. Intellectual impairment 2. Substance use disorder 3. Difficulties in adherence to medical or other treatment 4. Social and/or psychiatric problems to such an extent that they prevent focusing on treatment, or 5. Simultaneous psychological treatment

Design outcomes

Primary

MeasureTime frameDescription
Behavioral Activation for Depression Scale14 weeksTotal score 0-150; higher scores represent increased activation
Pure Procrastination Scale14 weeksTotal score 12-60; higher scores represent more procrastination

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026